Abreva Shortened Healing Time, Duration Of Cold Sores Stressed In Promos
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham's Abreva, now hitting shelves in food, drug and mass outlets, is the first OTC indicated for shortening the healing time and duration of symptoms related to cold sores and fever blisters.
You may also be interested in...
Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.
Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.
Carmex Cold Sore Treatment Claims Exceed Monograph Limit In NAD Review
Carma Labs’ Carmex Cold Sore Treatment claims did not mirror language in two OTC monographs for its active ingredients, the National Advertising Division says in a review of packaging and advertising claims challenged by GlaxoSmithKline's consumer business.